AI to the rescue: new study aims to ease mental health struggles in breast cancer patients
NCT ID NCT07409298
First seen Feb 15, 2026 · Last updated May 19, 2026 · Updated 14 times
Summary
This study tests whether an artificial intelligence-based management model can reduce anxiety and depression in 300 women with HR+/HER2- breast cancer who are taking CDK4/6 inhibitor pills at home. Participants will be randomly assigned to one of three follow-up approaches: AI-guided, customized active follow-up, or standard education. The goal is to see which model best improves emotional well-being and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Tianjin Medical University Cancer Institute & Hospital
Tianjin, 300000, China
Conditions
Explore the condition pages connected to this study.